Abivax S.A. - ABVX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | TCG Crossover GP I, LLC | 5.7% | 4,924,377 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | TCG Crossover Fund I, L.P. | 5.7% | 4,924,377 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | TCG Crossover GP II, LLC | 1.3% | 1,083,457 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | TCG Crossover Fund II, L.P. | 1.3% | 1,083,457 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Chen Yu | 7.0% | 6,007,834 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Invus Public Equities, L.P. | 6.0% | 4,790,187 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Invus Public Equities Advisors, LLC | 6.0% | 4,790,187 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Invus Global Management, LLC | 6.0% | 4,790,187 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Siren, L.L.C. | 6.0% | 4,790,187 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master Fund LP | 0.0% | 35,572 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master GP LLC | 0.0% | 35,572 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Ulys, L.L.C. | 0.0% | 35,572 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Raymond Debbane | 6.0% | 4,825,759 | View |
| Jul 06, 2026 | SCHEDULE 13D/A | — | 3.1% | 82,130,598 | View |
| May 11, 2026 | SCHEDULE 13D/A | — | 4.3% | 82,047,884 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.